Ruggaard & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$686K Hold
2,807
0.27% 54
2025
Q4
$581K Hold
2,807
0.23% 58
2025
Q3
$520K Sell
2,807
-1
-0% -$171 0.19% 64
2025
Q2
$429K Sell
2,808
-1,170
-29% -$180K 0.17% 72
2025
Q1
$660K Sell
3,978
-125
-3% -$19.6K 0.29% 48
2024
Q4
$593K Sell
4,103
-3
-0.1% -$465 0.26% 51
2024
Q3
$665K Sell
4,106
-50
-1% -$7.97K 0.29% 46
2024
Q2
$607K Sell
4,156
-9
-0.2% -$1.34K 0.28% 52
2024
Q1
$659K Sell
4,165
-55
-1% -$8.75K 0.31% 44
2023
Q4
$661K Sell
4,220
-188
-4% -$28.8K 0.35% 40
2023
Q3
$687K Sell
4,408
-90
-2% -$14.9K 0.41% 29
2023
Q2
$745K Sell
4,498
-66
-1% -$10.7K 0.44% 24
2023
Q1
$707K Buy
+4,564
New +$737K 0.44% 25

Other funds holding JNJ

Ruggaard & Associates's JNJ Position: Q1 2026 in Review

Ruggaard & Associates held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 2,807 shares worth $686K. The position accounts for 0.27% of the portfolio, ranked #54.

Ruggaard & Associates first reported a position in JNJ in Q1 2023 and has held it in 13 quarters since. The position peaked at $745K in Q2 2023. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Ruggaard & Associates held 2,807 shares of Johnson & Johnson worth $686K as of Q1 2026.
  • Ruggaard & Associates left its Johnson & Johnson share count unchanged in Q1 2026.
  • Johnson & Johnson made up 0.27% of Ruggaard & Associates's portfolio in Q1 2026, its #54 holding.
  • Ruggaard & Associates first reported a position in Johnson & Johnson in Q1 2023 and has held it in 13 quarters since.
  • Ruggaard & Associates's Johnson & Johnson position peaked at $745K in Q2 2023.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Ruggaard & Associates's 13F filing for Q1 2026, filed 26 May 2026.